AlumierMD Radiant TXA Peel

AlumierMD has expanded its professional peel line with the introduction of the Radiant TXA Peel, a formulation designed specifically to address discolouration and uneven tone in clinic-treated skin. The launch reflects a growing demand for treatments that offer both visible results and minimal recovery time.

At the heart of the formula is tranexamic acid (TXA) at a clinical concentration of 1.95%, paired with 30% lactic acid and an extract of white shiitake mushroom. While TXA has been gaining traction for its pigment-regulating properties, AlumierMD’s blend seeks to balance efficacy with skin tolerance — a key consideration in professional resurfacing treatments. Lactic acid serves a dual function, exfoliating while drawing moisture into the skin, and the mushroom extract brings added brightening support through tyrosinase inhibition.

The company has been deliberate in its positioning of the Radiant TXA Peel. It’s not pitched as aggressive or revolutionary but as a practical tool for managing hyperpigmentation, including melasma and post-inflammatory marks, in a repeatable, low-downtime protocol.

The peel enters a crowded field, but one that still struggles with inclusivity. Many chemical peels remain unsuitable for deeper Fitzpatrick types due to the risk of triggering rebound pigmentation. AlumierMD’s Radiant TXA has been formulated to work safely across all skin tones, with early in-clinic results indicating improvements in clarity and brightness after a single session — though cumulative use is recommended.

The peel is available exclusively through trained medical aesthetic providers and forms part of AlumierMD’s broader strategy to tighten the link between in-clinic protocols and homecare routines.

Become an AlumierMD partner here.